Training in Image Guidance, Precision Diagnosis and Therapy

拟议的T32培训计划提供图像引导治疗(IGT)培训。它是逻辑上的扩展 我们的国家影像指导治疗中心(NCIGT：P41 EB 015898)计划在布里格姆和 女子医院。这是一个独特的环境--即先进的多模式图像引导操作 会议室(Amigo)-基础设施和专业知识并存的地方，从基础生物学提供IGT培训 和病理学，到翻译研究和第二阶段临床试验。我们所有的Amigo临床项目都提供 为患者提供最先进的护理，辅之以成像和尖端研究机会。所有的 目前在Amigo工作的团队是多学科的(医学博士和博士)。我们的培训计划代表着 IGT的独特方法。在其他地方，没有其他真正多学科的培训结构可用 在先进的多模式介入/术中环境中学习技术和临床应用。 推进IGT领域的关键问题之一是缺乏受过专门培训的研究人员 回应医疗和技术进步的需求。这个节目的意义在于它 为医学博士和博士生提供技术和临床基础知识。培训内容包括 推进这一领域所需的相关概念、方法、技术和处理 为未来IGT相关应用提供训练有素的调查人员。因此，这一培训计划将 为希望使用复杂的先进技术进行培训的医生和科学家提供机会 可以诊断、定位和治疗多种疾病。通过多学科协作，我们的 培训计划将扩大新的诊断和治疗模式的专家库。我们将实施 动态、个性化的主题培训课程，将作为突破性技术进行更新 被发现并被带到临床翻译。我们的目标是让每一位IGT学员遵循一个主题 与他们之前的培训和经验与他们未来的职业目标最匹配的个性化计划。AS 该培训计划旨在通过IGT应用程序进行精确诊断和治疗，应聘者 人才库将是博士后-医学博士和博士，他们高度有动力学习先进的IGT技术和 创新的新临床应用，聘用时间为1年，可能延长至2年。超过了 在培训过程中，学员将接触到专业课程和教学课程，同时专注于 在IGT领域内各自感兴趣的主题领域的研究项目。必修课程作业 将包括了解生物标记物的科学，各种与IGT相关的培训活动，如 全面的、与临床相关的审查和实践经验，以及现有的和新兴的 技术，参与尖端研究项目，成功拨款的战略和 研究成果的有效沟通。预期的结果是，受训者将成为未来的学术领袖 IGT相关诊断和干预的技术发展和实施。

The proposed T32 training program provides image guided therapy (IGT) training. It is a logical extension of our National Center for Image Guided Therapy (NCIGT: P41 EB 015898) program at the Brigham and Women’s Hospital. This is a unique environment-namely the advanced multi-modal image-guided operating rooms (AMIGO)-where the infrastructure and expertise co-exist to provide training in IGT from basic biology and pathology, to translational studies and Phase 2 clinical trials. All our AMIGO clinical programs provide state of the art care for patients, supplemented with imaging and cutting-edge research opportunities. All the teams currently working in AMIGO are multidisciplinary (MDs & PhDs). Our training program represents a unique approach to IGT. There are no other genuinely multidisciplinary, training structures available elsewhere to learn techniques and clinical applications in an advanced multimodality interventional/intraoperative setting. One of the critical issues of advancing the field of IGT is the lack of specially trained investigators who can respond to both the medical and technological needs of progress. The significance of this program is that it provides both the technological and clinical fundamentals for both MD and PhD trainees. The training includes the relevant concepts, methods, technologies and treatments that are necessary to advance this field and provide fully trained investigators for future IGT- related applications. This training program will therefore provide an opportunity for physicians and scientists who wish to train with the complex advanced technology that can diagnose, localize, and treat many types of diseases. Through multidisciplinary collaboration, our training program will expand the pool of experts of new diagnostic and treatment modalities. We will implement a dynamic, personalized thematic-based training curriculum that will be updated as breakthrough technologies are discovered and brought to clinical translation. Our goal is for each IGT-trainee to follow a thematic personalized program that best matches their prior training and experience with their future career goals. As this training program is aimed at precision diagnostics and therapy through IGT applications, the candidate pool will be post-doctorates-MDs and PhDs who are highly motivated to learn advanced IGT technologies and innovative new clinical applications, who will be hired for 1 year, with a possible extension to 2 years. Over the course of the training, fellows are exposed to both specialized and didactic curriculum, while concentrating on a research project in their own thematic area of interest within the field of IGT. Required program coursework will include understanding the science of biomarkers, a wide variety of IGT-related training activities such as a comprehensive, clinically-relevant review and hands-on experience with the available and emerging technologies, participation in cutting-edge research projects, strategies for successful grant writing and effective communication of research. The intended outcome is that trainees will be future academic leaders in the technological developments and implementation of IGT-related diagnostics and interventions.